Omnicell Stock Debt To Equity

OMCL Stock

USD 27.86 0.73 2.69%

Omnicell fundamentals help investors to digest information that contributes to Omnicell's financial success or failures. It also enables traders to predict the movement of Omnicell Stock. The fundamental analysis module provides a way to measure Omnicell's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Omnicell stock.

		Last Reported	Projected for Next Year
	Debt To Equity	0.49	0.51

Debt To Equity is expected to rise to 0.51 this year.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Omnicell Company Debt To Equity Analysis

Omnicell's Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.

D/E

Total Debt

Total Equity

More About Debt To Equity | All Equity Analysis

Current Omnicell Debt To Equity

0.57 %

Most of Omnicell's fundamental indicators, such as Debt To Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Omnicell is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Omnicell Debt To Equity Driver Correlations

Understanding the fundamental principles of building solid financial models for Omnicell is extremely important. It helps to project a fair market value of Omnicell Stock properly, considering its historical fundamentals such as Debt To Equity. Since Omnicell's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Omnicell's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Omnicell's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Long Term Debt	Net Receivables	Short Term Investments	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Property Plant Equipment	Good Will	Intangible Assets	Treasury Stock	Net Tangible Assets	Capital Surpluse	Deferred Long Term Liab	Long Term Investments	Long Term Debt Total	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.99	0.96	0.69	0.98	0.76	0.96	0.94	0.79	0.99	0.98	0.37	-0.39	0.96	0.99	0.94	-0.93	0.2	0.92	-0.34	0.8	0.8	0.89	0.68	0.5	0.9
Total Stockholder Equity	0.99		0.95	0.6	0.99	0.77	0.9	0.94	0.82	0.94	0.97	0.36	-0.47	0.95	0.96	0.91	-0.92	0.27	0.91	-0.33	0.77	0.74	0.92	0.65	0.49	0.87
Current Deferred Revenue	0.96	0.95		0.71	0.96	0.75	0.89	0.97	0.69	0.94	0.93	0.26	-0.53	0.91	0.96	0.96	-0.94	0.13	0.86	-0.19	0.79	0.68	0.82	0.62	0.48	0.81
Net Debt	0.69	0.6	0.71		0.64	0.72	0.76	0.77	0.36	0.77	0.59	0.3	-0.08	0.65	0.77	0.8	-0.75	-0.24	0.65	-0.02	0.62	0.5	0.5	0.41	0.22	0.52
Retained Earnings	0.98	0.99	0.96	0.64		0.8	0.89	0.96	0.8	0.94	0.96	0.36	-0.46	0.94	0.96	0.91	-0.95	0.26	0.92	-0.28	0.77	0.71	0.91	0.65	0.48	0.84
Accounts Payable	0.76	0.77	0.75	0.72	0.8		0.68	0.83	0.55	0.74	0.68	0.57	-0.41	0.74	0.78	0.75	-0.8	0.09	0.84	0.04	0.57	0.39	0.66	0.34	0.15	0.45
Long Term Debt	0.96	0.9	0.89	0.76	0.89	0.68		0.85	0.71	0.99	0.94	0.39	-0.24	0.91	0.96	0.92	-0.87	0.07	0.86	-0.37	0.78	0.89	0.78	0.66	0.48	0.9
Net Receivables	0.94	0.94	0.97	0.77	0.96	0.83	0.85		0.73	0.91	0.89	0.27	-0.43	0.88	0.95	0.92	-0.95	0.15	0.88	-0.19	0.78	0.6	0.86	0.62	0.45	0.77
Short Term Investments	0.79	0.82	0.69	0.36	0.8	0.55	0.71	0.73		0.74	0.81	0.25	-0.18	0.72	0.74	0.58	-0.64	0.45	0.77	-0.48	0.64	0.57	0.93	0.6	0.48	0.74
Total Liab	0.99	0.94	0.94	0.77	0.94	0.74	0.99	0.91	0.74		0.97	0.36	-0.3	0.93	0.99	0.94	-0.92	0.13	0.9	-0.35	0.81	0.85	0.83	0.69	0.51	0.9
Total Current Assets	0.98	0.97	0.93	0.59	0.96	0.68	0.94	0.89	0.81	0.97		0.29	-0.4	0.92	0.96	0.88	-0.9	0.28	0.9	-0.44	0.8	0.84	0.88	0.74	0.59	0.92
Short Term Debt	0.37	0.36	0.26	0.3	0.36	0.57	0.39	0.27	0.25	0.36	0.29		-0.09	0.51	0.4	0.4	-0.26	-0.12	0.38	0.28	0.0	0.33	0.27	-0.31	-0.5	0.23
Common Stock	-0.39	-0.47	-0.53	-0.08	-0.46	-0.41	-0.24	-0.43	-0.18	-0.3	-0.4	-0.09		-0.4	-0.35	-0.43	0.45	-0.01	-0.31	-0.12	-0.23	-0.13	-0.25	-0.15	-0.12	-0.18
Property Plant Equipment	0.96	0.95	0.91	0.65	0.94	0.74	0.91	0.88	0.72	0.93	0.92	0.51	-0.4		0.97	0.94	-0.86	0.03	0.86	-0.26	0.73	0.82	0.83	0.53	0.31	0.89
Good Will	0.99	0.96	0.96	0.77	0.96	0.78	0.96	0.95	0.74	0.99	0.96	0.4	-0.35	0.97		0.97	-0.93	0.09	0.9	-0.29	0.8	0.81	0.85	0.64	0.44	0.89
Intangible Assets	0.94	0.91	0.96	0.8	0.91	0.75	0.92	0.92	0.58	0.94	0.88	0.4	-0.43	0.94	0.97		-0.91	-0.07	0.83	-0.14	0.75	0.75	0.74	0.53	0.34	0.82
Treasury Stock	-0.93	-0.92	-0.94	-0.75	-0.95	-0.8	-0.87	-0.95	-0.64	-0.92	-0.9	-0.26	0.45	-0.86	-0.93	-0.91		-0.14	-0.89	0.18	-0.8	-0.67	-0.79	-0.67	-0.52	-0.76
Net Tangible Assets	0.2	0.27	0.13	-0.24	0.26	0.09	0.07	0.15	0.45	0.13	0.28	-0.12	-0.01	0.03	0.09	-0.07	-0.14		0.26	-0.34	0.07	-0.04	0.45	0.3	0.45	0.14
Capital Surpluse	0.92	0.91	0.86	0.65	0.92	0.84	0.86	0.88	0.77	0.9	0.9	0.38	-0.31	0.86	0.9	0.83	-0.89	0.26		-0.31	0.87	0.69	0.86	0.71	0.54	0.74
Deferred Long Term Liab	-0.34	-0.33	-0.19	-0.02	-0.28	0.04	-0.37	-0.19	-0.48	-0.35	-0.44	0.28	-0.12	-0.26	-0.29	-0.14	0.18	-0.34	-0.31		-0.42	-0.53	-0.39	-0.69	-0.67	-0.55
Long Term Investments	0.8	0.77	0.79	0.62	0.77	0.57	0.78	0.78	0.64	0.81	0.8	0.0	-0.23	0.73	0.8	0.75	-0.8	0.07	0.87	-0.42		0.68	0.7	0.87	0.73	0.73
Long Term Debt Total	0.8	0.74	0.68	0.5	0.71	0.39	0.89	0.6	0.57	0.85	0.84	0.33	-0.13	0.82	0.81	0.75	-0.67	-0.04	0.69	-0.53	0.68		0.59	0.64	0.45	0.92
Short Long Term Debt	0.89	0.92	0.82	0.5	0.91	0.66	0.78	0.86	0.93	0.83	0.88	0.27	-0.25	0.83	0.85	0.74	-0.79	0.45	0.86	-0.39	0.7	0.59		0.63	0.51	0.78
Net Invested Capital	0.68	0.65	0.62	0.41	0.65	0.34	0.66	0.62	0.6	0.69	0.74	-0.31	-0.15	0.53	0.64	0.53	-0.67	0.3	0.71	-0.69	0.87	0.64	0.63		0.95	0.7
Net Working Capital	0.5	0.49	0.48	0.22	0.48	0.15	0.48	0.45	0.48	0.51	0.59	-0.5	-0.12	0.31	0.44	0.34	-0.52	0.45	0.54	-0.67	0.73	0.45	0.51	0.95		0.52
Capital Stock	0.9	0.87	0.81	0.52	0.84	0.45	0.9	0.77	0.74	0.9	0.92	0.23	-0.18	0.89	0.89	0.82	-0.76	0.14	0.74	-0.55	0.73	0.92	0.78	0.7	0.52

Click cells to compare fundamentals

High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.

Competition

Predict Omnicell

Debt To Equity Over Time

Omnicell Total Stockholder Equity

Total Stockholder Equity

1.25 Billion

At this time, Omnicell's Total Stockholder Equity is quite stable compared to the past year.

According to the company disclosure, Omnicell has a Debt To Equity of 0.567%. This is 98.94% lower than that of the Health Care Technology sector and significantly higher than that of the Health Care industry. The debt to equity for all United States stocks is 98.84% higher than that of the company.

Omnicell Debt To Equity Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Omnicell's direct or indirect competition against its Debt To Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Omnicell could also be used in its relative valuation, which is a method of valuing Omnicell by comparing valuation metrics of similar companies.

Omnicell is currently under evaluation in debt to equity category among related companies.

Omnicell Fundamentals

	Return On Equity	-0.0176
	Return On Asset	-0.0061
	Profit Margin	(0.02) %
	Operating Margin	(0.09) %
	Current Valuation	1.43 B
	Shares Outstanding	45.92 M
	Shares Owned By Insiders	1.40 %
	Shares Owned By Institutions	98.60 %
	Number Of Shares Shorted	2.37 M
	Price To Earning	64.95 X
	Price To Book	1.05 X
	Price To Sales	1.09 X
	Revenue	1.15 B
	Gross Profit	596.71 M
	EBITDA	(34.87 M)
	Net Income	(20.37 M)
	Cash And Equivalents	244.95 M
	Cash Per Share	5.53 X
	Total Debt	614.09 M
	Debt To Equity	0.57 %
	Current Ratio	2.11 X
	Book Value Per Share	26.11 X
	Cash Flow From Operations	181.09 M
	Short Ratio	4.78 X
	Earnings Per Share	(0.45) X
	Price To Earnings To Growth	2.28 X
	Target Price	34.5
	Number Of Employees	3.65 K
	Beta	0.76
	Market Capitalization	1.28 B
	Total Asset	2.23 B
	Retained Earnings	370.36 M
	Working Capital	559.78 M
	Current Asset	50.15 M
	Current Liabilities	50.17 M
	Net Asset	2.23 B

About Omnicell Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Omnicell's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Omnicell using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Omnicell based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Omnicell is a strong investment it is important to analyze Omnicell's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Omnicell's future performance. For an informed investment choice regarding Omnicell Stock, refer to the following important reports:

How To Invest In Omnicell

Details

Is Omnicell Stock a good investment?

Details

What is Omnicell's Net Worth?

Details

Largest Health Care Technology Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Omnicell Piotroski F Score and Omnicell Altman Z Score analysis.

For more information on how to buy Omnicell Stock please use our How to buy in Omnicell Stock guide.

Note that the Omnicell information on this page should be used as a complementary analysis to other Omnicell's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Complementary Tools for Omnicell Stock analysis

When running Omnicell's price analysis, check to measure Omnicell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Omnicell is operating at the current time. Most of Omnicell's value examination focuses on studying past and present price action to predict the probability of Omnicell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Omnicell's price. Additionally, you may evaluate how the addition of Omnicell to your portfolios can decrease your overall portfolio volatility.

	Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
	Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
	Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
	Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated
	Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
	Analyst Advice Analyst recommendations and target price estimates broken down by several categories
	ETFs Find actively traded Exchange Traded Funds (ETF) from around the world
	Portfolio Anywhere Track or share privately all of your investments from the convenience of any device
	Commodity Directory Find actively traded commodities issued by global exchanges
	ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments

Is Omnicell's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Omnicell. If investors know Omnicell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Omnicell listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.68)

Earnings Share

(0.45)

Revenue Per Share

25.372

Quarterly Revenue Growth

(0.13)

Return On Assets

(0.01)

The market value of Omnicell is measured differently than its book value, which is the value of Omnicell that is recorded on the company's balance sheet. Investors also form their own opinion of Omnicell's value that differs from its market value or its book value, called intrinsic value, which is Omnicell's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Omnicell's market value can be influenced by many factors that don't directly affect Omnicell's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Omnicell's value and its price as these two are different measures arrived at by different means. Investors typically determine if Omnicell is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Omnicell's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Omnicell Stock Debt To Equity

Omnicell Company Debt To Equity Analysis

D/E

Total Debt

Total Equity

Current Omnicell Debt To Equity

Omnicell Debt To Equity Driver Correlations

Omnicell Total Stockholder Equity

Total Stockholder Equity

1.25 Billion

Omnicell Debt To Equity Peer Comparison

Omnicell Fundamentals

About Omnicell Fundamental Analysis

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Complementary Tools for Omnicell Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY